Zurzuvae (Zuranolone)

Zurzuvae (zuranolone) is a neuroactive steroid gamma-aminobutyric acid (GABA) A receptor positive modulator used for the treatment of postpartum depression (PPD) in adults.

Recommended Dosage: The recommended dosage of Zurzuvae is 50 mg taken orally once daily in the evening for 14 days. Administer this therapeutic drug with fat-containing food (e.g., 400-1,000 calories, 25-50% fat). If patients experience CNS depressant effects within the 14-day period, consider reducing the dosage to 40 mg once daily in the evening within the 14-day period. Zurzuvae can be used alone or as an adjunct to oral antidepressant therapy.

The safety and effectiveness of Zurzuvae capsules use beyond 14 days in a single treatment course have not been established.

• Treatment with Zuranolone causes driving impairment because of central nervous system (CNS) depressant effects. Patients should avoid driving a motor vehicle or engaging in other potentially hazardous activities requiring complete mental alertness, such as operating machinery, until at least 12 hours after Zuranolone administration for the duration of the 14-day treatment course.
• Zuranolone can cause CNS depressant effects such as somnolence and confusion. Because this drug can cause CNS depressant effects, patients may be at greater risk of falls. In case patients develop CNS depressant effects, consider dosage reduction or discontinuation of treatment. If use with another CNS depressant is unavoidable, consider dosage reduction.  
• Consider changing the therapeutic regimen, including discontinuing Zuranolone, in those whose PPD worsens, or who experience emergent suicidal thoughts and behaviors.
• This medicinal product may cause fetal harm when administered to a pregnant woman. Females of reproductive potential should use effective contraception during treatment and for one week after the final dose.

What documents are required to import ZURZUVAE to India?

ZURZUVAE (zuranolone) capsules can be imported by patients or government hospitals on the name of the patients only. 

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patients ID proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from Doctor
• Import permit if applicable

Is ZURZUVAE available in India?

ZURZUVAE (zuranolone capsules) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Zurzuvae in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

ZURZUVAE can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of ZURZUVAE (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Zurzuvae 20 mg/25 mg/30 mg price in India. 

We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network is able to source the ZURZUVAE (Cancer Treatment Medicines) from across the globe and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Zurzuvae®?

Zuranolone is a Generic Name for the trade name drug Zurzuvae®.

What is the Manufacturer’s Name of Zurzuvae®?

Zurzuvae® is manufactured by Sage Therapeutics and Biogen Inc.

Is Zurzuvae® approved by the FDA?

Yes, Zurzuvae® is approved by the FDA. Date of first approval: August 4, 2023.

What is the dosage and form of Zurzuvae® supplied?

Zurzuvae® is supplied as Capsules: 20 mg, 25 mg, and 30 mg for oral administration. 

Where can I get Zurzuvae® at the best price in India?

To get the best Zurzuvae price in India, kindly contact the Indian Pharma Network (a WHO GDP and ISO 9001:2008 certified company). For Zurzuvae®, a medical prescription is needed from a treating physician.

What are the most common side effects of Zurzuvae®? 

The most common side effects of Zurzuvae® are diarrhea, fatigue, somnolence, dizziness, urinary tract infection, and nasopharyngitis.

How much does Zurzuvae® cost in India?

The cost of Zurzuvae in India can vary. To procure this medication legally, you can call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

What are the storage conditions of Zurzuvae®?

Store the capsules at room temperature 20-25°C (68-77°F); excursions permitted between 15-30°C (59-86°F).

Is it safe to buy Zurzuvae® online in India?

Yes, one can buy Zurzuvae online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can facilitate the supply of Zurzuvae® through legal channels.